RPA
GILD icon

Rock Point Advisors’s Gilead Sciences GILD Stock Holding History

Rock Point Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,340
Closed -$2.17M – 95
2022
Q4 		$2.17M Sell
25,340
-21,764
-46% -$1.72M 0.75% 42
2022
Q3 		$2.91M Sell
47,104
-490
-1% -$30.9K 1.08% 34
2022
Q2 		$2.94M Sell
47,594
-34,961
-42% -$2.16M 1% 39
2022
Q1 		$4.91M Buy
82,555
+200
+0.2% +$12.8K 1.46% 32
2021
Q4 		$5.98M Buy
82,355
+27,826
+51% +$1.92M 1.68% 25
2021
Q3 		$3.81M Sell
54,529
-235
-0.4% -$16.5K 1.12% 41
2021
Q2 		$3.77M Buy
54,764
+1,035
+2% +$69.1K 1.09% 36
2021
Q1 		$3.47M Buy
53,729
+1,154
+2% +$74.4K 1.08% 35
2020
Q4 		$3.06M Buy
52,575
+21,537
+69% +$1.3M 1.05% 34
2020
Q3 		$1.96M Buy
31,038
+2,367
+8% +$164K 0.87% 37
2020
Q2 		$2.21M Sell
28,671
-28,741
-50% -$2.2M 1.03% 35
2020
Q1 		$4.29M Sell
57,412
-82,340
-59% -$5.69M 2.54% 15
2019
Q4 		$9.08M Buy
139,752
+2,515
+2% +$164K 3.69% 10
2019
Q3 		$8.7M Buy
137,237
+4,359
+3% +$285K 3.93% 9
2019
Q2 		$8.98M Buy
132,878
+799
+0.6% +$52.6K 4.08% 8
2019
Q1 		$8.59M Buy
132,079
+8
+0% +$532 4.04% 9
2018
Q4 		$8.26M Sell
132,071
-7,207
-5% -$504K 4.24% 7
2018
Q3 		$10.8M Sell
139,278
-415
-0.3% -$31.3K 4.79% 4
2018
Q2 		$9.9M Buy
139,693
+25,783
+23% +$1.82M 4.66% 6
2018
Q1 		$8.59M Sell
113,910
-3,180
-3% -$253K 4.23% 7
2017
Q4 		$8.39M Buy
117,090
+794
+0.7% +$60.3K 3.91% 9
2017
Q3 		$9.42M Sell
116,296
-7,481
-6% -$572K 4.39% 4
2017
Q2 		$8.76M Buy
123,777
+3,472
+3% +$231K 4.12% 4
2017
Q1 		$8.17M Buy
120,305
+26,657
+28% +$1.87M 4.16% 8
2016
Q4 		$6.71M Buy
93,648
+46,088
+97% +$3.43M 3.45% 10
2016
Q3 		$3.76M Buy
47,560
+21,535
+83% +$1.75M 1.97% 19
2016
Q2 		$2.17M Buy
+26,025
New +$2.31M 1.16% 33

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rock Point Advisors's GILD Position: Q1 2023 in Review

Rock Point Advisors sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 25,340 shares — an estimated $2.17M sold.

Rock Point Advisors first reported a position in GILD in Q2 2016 and held it in 27 quarters. The position peaked at $10.8M in Q3 2018. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Rock Point Advisors reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Rock Point Advisors sold 25,340 Gilead Sciences shares in Q1 2023, an estimated $2.17M.
  • Rock Point Advisors first reported a position in Gilead Sciences in Q2 2016 and held it in 27 quarters.
  • Rock Point Advisors's Gilead Sciences position peaked at $10.8M in Q3 2018.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Rock Point Advisors's 13F filing for Q1 2023, filed 10 May 2023.